Exicure, Inc. (XCUR) Financials
XCUR Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-06-30 | 23.9 million | 9.3 million |
| 2023-03-31 | 23.9 million | 9.3 million |
| 2022-12-31 | 23.3 million | 8.4 million |
| 2022-09-30 | 28.9 million | 32.6 million |
XCUR Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-06-30 | -3.3 million | 308000 |
| 2023-03-31 | -3.3 million | 308000 |
| 2022-12-31 | -7.3 million | 228000 |
| 2022-09-30 | -6.5 million | 292000 |
XCUR Net Income
No data available :(
XCUR Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-06-30 | 10.0 million | - | 6.4 million |
| 2023-03-31 | - | - | 6.6 million |
| 2022-12-31 | 8.6 million | - | 7.3 million |
| 2022-09-30 | 15.6 million | - | 7.5 million |
XCUR Shares Outstanding
XCUR Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-06-30 | - | 2.0 million | 2.6 million | - |
| 2023-03-31 | - | 2.0 million | 2.6 million | - |
| 2022-12-31 | 10000 | 1.1 million | 2.1 million | - |
| 2022-09-30 | 4 | 4.8 million | 2.4 million | - |
XCUR Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-06-30 | 2.5 million | 431000 |
| 2023-03-31 | - | - |
| 2022-12-31 | 21.8 million | 458000 |
| 2022-09-30 | 2.0 million | 464000 |
XCUR
Price: $0.50
52 week price:
Earnings Per Share: 1.77 USD
P/E Ratio: 0.33
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 9300
Market Capitalization: 4.4 million